- Home
- AQST vs FBIZ Comparison
AQST vs FBIZ Comparison
Compare AQST & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- FBIZ
- Stock Information
- Founded
- AQST 2004
- FBIZ 1909
- Country
- AQST United States
- FBIZ United States
- Employees
- AQST N/A
- FBIZ N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- FBIZ Major Banks
- Sector
- AQST Health Care
- FBIZ Finance
- Exchange
- AQST Nasdaq
- FBIZ Nasdaq
- Market Cap
- AQST 390.4M
- FBIZ 390.3M
- IPO Year
- AQST 2018
- FBIZ N/A
- Fundamental
- Price
- AQST $5.12
- FBIZ $51.93
- Analyst Decision
- AQST Strong Buy
- FBIZ Buy
- Analyst Count
- AQST 7
- FBIZ 3
- Target Price
- AQST $10.29
- FBIZ $58.67
- AVG Volume (30 Days)
- AQST 2.4M
- FBIZ 22.4K
- Earning Date
- AQST 11-03-2025
- FBIZ 10-23-2025
- Dividend Yield
- AQST N/A
- FBIZ 2.25%
- EPS Growth
- AQST N/A
- FBIZ 22.50
- EPS
- AQST N/A
- FBIZ 5.60
- Revenue
- AQST $44,132,000.00
- FBIZ $150,952,000.00
- Revenue This Year
- AQST N/A
- FBIZ $17.98
- Revenue Next Year
- AQST $38.71
- FBIZ $8.26
- P/E Ratio
- AQST N/A
- FBIZ $9.23
- Revenue Growth
- AQST N/A
- FBIZ 8.24
- 52 Week Low
- AQST $2.12
- FBIZ $41.47
- 52 Week High
- AQST $5.80
- FBIZ $56.46
- Technical
- Relative Strength Index (RSI)
- AQST 67.40
- FBIZ 55.48
- Support Level
- AQST $4.91
- FBIZ $51.57
- Resistance Level
- AQST $5.27
- FBIZ $52.54
- Average True Range (ATR)
- AQST 0.29
- FBIZ 0.79
- MACD
- AQST 0.08
- FBIZ -0.02
- Stochastic Oscillator
- AQST 74.39
- FBIZ 39.37
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.